BAIYUNSHAN PH(00874.HK)

Last Updated 08:00:00
longbridge loading

Guangzhou Baiyunshan Pharma Sets Vote on New Three-Year Board Line-Up

Tip Ranks·
HK
00874
-0.86%
SZ
159849
-0.21%
SH
513120
-0.44%
Tip Ranks·
HK
00874
-0.86%
SZ
159849
-0.21%
SH
513120
-0.44%

Baiyunshan Q1 Revenue Rises as Profit Margins Narrow and Cash Outflows Ease

Tip Ranks·
SH
600332
-1.40%
HK
00874
-0.86%
Tip Ranks·
SH
600332
-1.40%
HK
00874
-0.86%

"Performance" Baiyunshan's annual net profit is 2.983 billion RMB, an increase of 5.2%, with a final dividend of 0.45 yuan

AASTOCKS·
SH
589720
+1.03%
SZ
159859
-0.55%
SZ
159506
-0.75%
AASTOCKS·
SH
589720
+1.03%
SZ
159859
-0.55%
SZ
159506
-0.75%

With only six months left until July 1, 2026, the implementation of Article 75 of the National Medical Products Administration's "Special Regulations on the Registration of Traditional Chinese Medicine" is entering its final window period. This regulation, referred to in the industry as the "death clause" for proprietary Chinese medicines, clearly states that after three years of implementation starting from July 1, 2023, the contraindications in the instructions will be prohibited

Wallstreetcn·
SH
512290
-0.11%
SZ
159929
-0.71%
SH
600436
-0.77%
Wallstreetcn·
SH
512290
-0.11%
SZ
159929
-0.71%
SH
600436
-0.77%

BAIYUNSHAN PH plans to develop an advanced manufacturing center in Hong Kong

AASTOCKS·
SH
600332
-1.40%
HK
00874
-0.86%
AASTOCKS·
SH
600332
-1.40%
HK
00874
-0.86%

BAIYUNSHAN PH fully acquires ZMC distribution company for a consideration of 500 million RMB

AASTOCKS·
SH
600216
-2.12%
SH
600332
-1.40%
HK
00874
-0.86%
AASTOCKS·
SH
600216
-2.12%
SH
600332
-1.40%
HK
00874
-0.86%

Hong Kong Stock Movement: IVD MEDICAL fell 12.86%, with no news support, the sector's volatility has attracted market attention

HK Stock Alerts·
HK
01931
-3.37%
HK
00874
-0.86%
HK
09885
+6.56%
HK Stock Alerts·
HK
01931
-3.37%
HK
00874
-0.86%
HK
09885
+6.56%

Guangyao Group established an animal health technology company with a registered capital of 200 million

Zhitong·
SH
600332
-1.40%
HK
00874
-0.86%
Zhitong·
SH
600332
-1.40%
HK
00874
-0.86%

Understanding the Market | BAIYUNSHAN PH rose over 4% after earnings, with net profit attributable to shareholders for the first three quarters at 3.31 billion yuan; its Wanglaoji International can product has debuted in the Middle East market

Zhitong·
SH
600332
-1.40%
HK
00874
-0.86%
Zhitong·
SH
600332
-1.40%
HK
00874
-0.86%
© 2026 Longbridge｜Disclaimer